[00:23:00] Um, definitely I see how it influences fertility and there's great studies on that, but it just shifts timing of people's periods as well
Look for the retention time, which should be consistent with known retatrutide standards
While these medications are FDA-approved for diabetes and weight loss, their use for perimenopause is considered off-label
Visceral fat reduction decreases chronic low-grade inflammation (inflammaging), a key driver of age-related pathology ( 3.2 Growth hormone axis restoration Growth hormone (GH) secretion declines approximately 14% per decade after age 30, resulting in decreased lean body mass, increased adiposity (particularly visceral fat), reduced bone density, decreased skin thickness, and impaired recovery from illness or injury, a phenomenon termed somatopause ( CJC-1295, a long-acting GHRH analog incorporating a Drug Affinity Complex (DAC) for albumin binding, addresses somatopause by restoring more youthful GH secretion patterns ( Ipamorelin complements CJC-1295 by stimulating GH release through ghrelin receptor activation rather than GHRH pathways (Malavige et al., 2021)
AOD-9604 does not touch appetite